Overview

The Drug-drug Interaction of SP2086 and Metformin

Status:
Completed

Trial end date:
1969-12-31

Target enrollment:

Participant gender:

Summary

This is an open single and self-control study,planning to recruit 24 cases of healthy male volunteers.In the study,subjects were given SP2086 and metformin,and collects blood samples before and after medcine.The purpose is to evaluate the drug interaction between SP2086 and Metformin.

Phase:

Phase 1

Details

Lead Sponsor:

Jiangsu HengRui Medicine Co., Ltd.

Treatments:

Metformin